Report states that Divi's Laboratories Ltd has passed into a long-term supply agreement pact with a global company in pharmaceuticals for the manufacture and supply of advanced intermediates. Though the partner remains...
Japan-based Ono Pharmaceutical has entered into a partnership with the United States' Jorna Therapeutics to develop innovative RNA-editing therapeutics. Announced in December, the collaboration builds...
The central government is pushing to mainstream swap kidney transplants through a unified national programme—a move experts believe could increase kidney transplant volumes by up to 15%. Swap transplants, or paired kidney exchanges, allow organ shari
The tumor antigen-specific antibody sequence has been licensed exclusively to GC Cell, a gene and cell therapy company, by DAAN Biotherapeutics, a leading novel drug development company that specializes in T-Cell receptor (TCR)-based medicines.
Rapid advancements in stem cell therapy are seen in India based on government support, private funding and a strong academic research ecosystem. Dr. Mrinalini Chaturvedi, Medical Director of Cryoviva Life Sciences, says ...
.png)
Meril Genomics, a reputable diagnostics and molecular biology provider, and Vgenomics, a leading precision health firm, have announced a ground-breaking collaboration to supply hospitals and research facilities across India with complementing....
.png)
AbbVie, the biopharmaceutical company, announced the launch of Venetoclax for the treatment of Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL) in India on AML World Awareness Day. This makes AbbVie the latest entrant into the.....
In a remarkable milestone, India’s yearly drug and pharmaceutical exports reached an all-time high of $30 billion in Fiscal Year 2025, fueled by a 31 percent increase compared to the previous year in March...
Eli Lilly’s experimental weight-loss pill, orforglipron, achieved nearly 8% weight loss and notable blood sugar reduction in a late-stage trial for patients with type 2 diabetes. The once-daily oral drug exceeded Wall Street expectations, triggering
Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited specializing in medical technology development, has entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda...
, CDSCO.jpg)
